These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

523 related items for PubMed ID: 28055284

  • 21. Attenuation of monocrotaline-induced pulmonary arterial hypertension in rats by rosuvastatin.
    Li XL, Guan RJ, Li JJ.
    J Cardiovasc Pharmacol; 2012 Aug; 60(2):219-26. PubMed ID: 22592772
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Ang-(1-7) might prevent the development of monocrotaline induced pulmonary arterial hypertension in rats.
    Chen L, Xiao J, Li Y, Ma H.
    Eur Rev Med Pharmacol Sci; 2011 Jan; 15(1):1-7. PubMed ID: 21381494
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The extracellular signal-regulated kinase is involved in the effects of sildenafil on pulmonary vascular remodeling.
    Zeng Z, Li Y, Jiang Z, Wang C, Li B, Jiang W.
    Cardiovasc Ther; 2010 Jan; 28(1):23-9. PubMed ID: 20074256
    [Abstract] [Full Text] [Related]

  • 27. Inhibition of ubiquitin proteasome function prevents monocrotaline-induced pulmonary arterial remodeling.
    Zhu Y, Wu Y, Shi W, Wang J, Yan X, Wang Q, Liu Y, Yang L, Gao L, Li M.
    Life Sci; 2017 Mar 15; 173():36-42. PubMed ID: 28212825
    [Abstract] [Full Text] [Related]

  • 28. [Effects of apple polyphenols on monocrotaline-induced pulmonary vascular remodeling in rats and its mechanism].
    Zhang SH, Shao SM, Chen FZ, Zhu J, Chen LW, Wang H, Xiang XH, Yuan LB.
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2019 May 28; 35(3):209-214. PubMed ID: 31257800
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Cilostazol therapy attenuates monocrotaline-induced pulmonary arterial hypertension in rat model.
    Chang LT, Sun CK, Sheu JJ, Chiang CH, Youssef AA, Lee FY, Wu CJ, Yip HK.
    Circ J; 2008 May 28; 72(5):825-31. PubMed ID: 18441466
    [Abstract] [Full Text] [Related]

  • 31. Amlodipine prevents monocrotaline-induced pulmonary arterial hypertension and prolongs survival in rats independent of blood pressure lowering.
    Mawatari E, Hongo M, Sakai A, Terasawa F, Takahashi M, Yazaki Y, Kinoshita O, Ikeda U.
    Clin Exp Pharmacol Physiol; 2007 Jul 28; 34(7):594-600. PubMed ID: 17581214
    [Abstract] [Full Text] [Related]

  • 32. Magnolol ameliorates pneumonectomy and monocrotaline-induced pulmonary arterial hypertension in rats through inhibition of angiotensin II and endothelin-1 expression.
    Chang H, Chang CY, Lee HJ, Chou CY, Chou TC.
    Phytomedicine; 2018 Dec 01; 51():205-213. PubMed ID: 30466619
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. 3,7-Bis(2-hydroxyethyl)icaritin, a potent inhibitor of phosphodiesterase-5, prevents monocrotaline-induced pulmonary arterial hypertension via NO/cGMP activation in rats.
    Lan TH, Chen XL, Wu YS, Qiu HL, Li JZ, Ruan XM, Xu DP, Lin DQ.
    Eur J Pharmacol; 2018 Jun 15; 829():102-111. PubMed ID: 29665366
    [Abstract] [Full Text] [Related]

  • 35. Preventive treatment with atorvastatin ameliorates endothelial dysfunction of small pulmonary arteries in monocrotaline-induced pulmonary hypertensive rats.
    Lin Z, Jiang Z, Huang X, Cai X, Wang H, Xie L.
    Clin Exp Hypertens; 2017 Jun 15; 39(6):495-501. PubMed ID: 28628347
    [Abstract] [Full Text] [Related]

  • 36. Icotinib Attenuates Monocrotaline-Induced Pulmonary Hypertension by Preventing Pulmonary Arterial Smooth Muscle Cell Dysfunction.
    Peng LY, Yu M, Yang MX, Liu P, Zhou H, Huang W, Kong H, Xie WP.
    Am J Hypertens; 2020 Aug 04; 33(8):775-783. PubMed ID: 32301965
    [Abstract] [Full Text] [Related]

  • 37. Soluble guanylate cyclase stimulator, trans-4-methoxy-β-nitrostyrene, has a beneficial effect in monocrotaline-induced pulmonary arterial hypertension in rats.
    Gonzaga-Costa K, Vasconcelos-Silva AA, Rodrigues-Silva MJ, Rebouça CDSM, Duarte GP, Borges RS, Magalhães PJC, Lahlou S.
    Eur J Pharmacol; 2021 Apr 15; 897():173948. PubMed ID: 33609564
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Resveratrol inhibits monocrotaline-induced pulmonary arterial remodeling by suppression of SphK1-mediated NF-κB activation.
    Shi W, Zhai C, Feng W, Wang J, Zhu Y, Li S, Wang Q, Zhang Q, Yan X, Chai L, Liu P, Chen Y, Li M.
    Life Sci; 2018 Oct 01; 210():140-149. PubMed ID: 30179628
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.